Literature DB >> 11521122

Alternatives for women through menopause.

M L Gass1, M B Taylor.   

Abstract

Today, 42% of Americans use alternative nonprescription therapies to treat medical conditions; 46% of nonprescription alternative use for principal medical conditions is done without consulting either a medical doctor or a nonphysician practitioner of alternative therapy. Many nontraditional alternatives are used to treat the hot flashes and somatic complaints of menopause, for which options such as hormone replacement therapy and other prescription and over-the-counter drugs are also available. To date, no one agent treats all menopausal symptoms as effectively as estrogen. Selective estrogen-receptor modulators can help prevent osteoporosis but do not relieve menopausal symptoms. However, some women are unwilling or unable to take hormone replacement therapy, and some decide to discontinue therapy. Evidence supporting the use of some nonprescription alternatives for conditions related to menopause is limited. Patients need to be aware of the potential for drug interactions when these alternative therapies are used concomitantly with prescription drugs. The current evidence to support use of hormone replacement therapy, selective estrogen-receptor modulators, and nontraditional alternatives is reviewed here.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11521122     DOI: 10.1067/mob.2001.116524

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  A survey of the therapeutic effects of Vitamin E suppositories on vaginal atrophy in postmenopausal women.

Authors:  Aazam Parnan Emamverdikhan; Nahid Golmakani; Sayyed ASajadi Tabassi; Malihe Hassanzadeh; Nooriyeh Sharifi; Mohammad Taghi Shakeri
Journal:  Iran J Nurs Midwifery Res       Date:  2016 Sep-Oct

2.  Effect of Red Clover on CYP Expression: An Investigation of Herb-Drug Interaction at Molecular Level.

Authors:  Anubhuti Tripathi; S P Singh; K S R Raju; J R Gayen
Journal:  Indian J Pharm Sci       Date:  2014-05       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.